-
21
Recent advances of nanovaccines on cancer theranostics
Published 2025-02-01Subjects: Get full text
Article -
22
Early initiation of intravenous cyclophosphamide and one‐year outcome in super‐refractory cryptogenic‐new onset refractory status epilepticus
Published 2025-02-01Subjects: Get full text
Article -
23
-
24
Exploring the role and mechanisms of MAGEA4 in tumorigenesis, regulation, and immunotherapy
Published 2025-02-01Subjects: Get full text
Article -
25
Targeted therapy and immunotherapy for gastric cancer: rational strategies, novel advancements, challenges, and future perspectives
Published 2025-02-01Subjects: Get full text
Article -
26
Targeting HVEM-GPT2 axis: a novel approach to T cell activation and metabolic reprogramming in non-small cell lung cancer therapy
Published 2025-02-01Subjects: Get full text
Article -
27
Potential and development of cellular vesicle vaccines in cancer immunotherapy
Published 2025-01-01Subjects: Get full text
Article -
28
-
29
-
30
-
31
-
32
Autoimmune encephalitis: case reports of anti-NMDAR and anti-CASPR2 encephalitides and literature review
Published 2021-12-01Subjects: Get full text
Article -
33
-
34
Design of studies on neoadjuvant therapy for intrahepatic cholangiocarcinoma
Published 2025-01-01Subjects: Get full text
Article -
35
Cuproptosis: molecular mechanisms, cancer prognosis, and therapeutic applications
Published 2025-01-01Subjects: Get full text
Article -
36
On the global dynamics of a model for tumor immunotherapy
Published 2009-05-01Subjects: Get full text
Article -
37
A Narrative Review of Prognostic Gene Signatures in Oral Squamous Cell Carcinoma Using LASSO Cox Regression
Published 2025-01-01Subjects: Get full text
Article -
38
The interplay between persistent pathogen infections with tumor microenvironment and immunotherapy in cancer
Published 2024-09-01Subjects: Get full text
Article -
39
-
40